Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
In: Annals of Oncology, 2023
Online
academicJournal
Zugriff:
• This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing non-oncogene-addicted mNSCLC. • ESMO-MCBS scores are given to describe the levels of evidence for treatment choices. • ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies. • Recommendations are based on available scientific data and the authors’ collective expert opinion. • In clinical practice, all recommendations provided need to be discussed with patients in a shared decision-making approach. ; Pathogenesis and treatment of chronic pulmonary diseases
Titel: |
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|
---|---|
Autor/in / Beteiligte Person: | Hendriks, L.E. ; Kerr, K.M. ; Menis, J. ; Mok, T.S. ; Nestle, U. ; Passaro, A. ; Planchard, D. ; Peters, S. ; Smit, E.F. ; Solomon, B.J. ; Veronesi, G. ; Reck, M. ; SMO Guidelines Comm |
Link: | |
Zeitschrift: | Annals of Oncology, 2023 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
DOI: | 10.1016/j.annonc.2022.12.013 |
Schlagwort: |
|
Sonstiges: |
|